Effects of treatment with clopidogrel with or without proton pump inhibitor omeprazole on the risk of ischemic stroke: a nationwide cohort study
Abstract Most proton pump inhibitors (PPIs) inhibit the bioactivation of clopidogrel to its active metabolite. There is controversy concerning whether PPIs alter the effectiveness of clopidogrel in reducing the risk of ischemic stroke (IS). We therefore aimed to examine the risk of IS associated wit...
Main Authors: | Chao-Chien Chang, Yu-Ching Chou, Jin-Yin Chang, Chien-An Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-01-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-024-51682-8 |
Similar Items
-
Clopidogrel and proton pump inhibitor (PPI) interaction: separate intake and a non-omeprazole PPI the solution?
by: Kenngott S, et al.
Published: (2010-05-01) -
Impact of Concomitant Use of Proton Pump Inhibitors and Clopidogrel on Recurrent Stroke and Myocardial Infarction
by: Yong Kang Lee, et al.
Published: (2023-08-01) -
Proton Pump Inhibitors Increase the Risk of Autoimmune Diseases: A Nationwide Cohort Study
by: Sheng-Hong Lin, et al.
Published: (2021-09-01) -
Platelets prohibition with clopidogrel alone versus with proton-pump inhibitors
by: Feryal Hashim Rada
Published: (2021-01-01) -
Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan.
by: Shu-Yu Tai, et al.
Published: (2017-01-01)